Management of elderly patients with urothelial carcinoma of the bladder: Guideline concordance and predictors of overall survival

BJU International

Volumn 106, Issue 9, 2010, Pages 1324-1329

  Bolenz, Christian ^a,b   Ho, Richard ^a   Nuss, Geoffrey R ^a   Ortiz, Nicolas ^a   Raj, Ganesh V ^a   Sagalowsky, Arthur I ^a   Lotan, Yair ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

bladder cancer; clinical protocols; comorbidity; guidelines; Karnofsky performance status; survival analysis

Indexed keywords

BCG VACCINE; CISPLATIN DERIVATIVE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BLADDER CARCINOMA; BLOOD TRANSFUSION REACTION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CONSERVATIVE TREATMENT; CYSTECTOMY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FEVER; HEART INFARCTION; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPOTENSION; ILEUS; KARNOFSKY PERFORMANCE STATUS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; POSTOPERATIVE HEMORRHAGE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SMALL INTESTINE OBSTRUCTION; TRANSURETHRAL RESECTION; TREATMENT INDICATION; UNIVARIATE ANALYSIS; UROTHELIAL CARCINOMA OF THE BLADDER;

AGE FACTORS; AGED; AGED, 80 AND OVER; CYSTECTOMY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 78149399964     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09417.x     Document Type: Article

References (18)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49
2. Yancik R., Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 1997; 80: 1273-83
3. Madeb R, Messing EM,. Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 2004; 22: 86-92
4. Koppie TM, Serio AM, Vickers AJ, et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008; 112: 2384-92
5. Miller DC, Taub DA, Dunn RL, Montie JE, Wei JT,. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol 2003; 169: 105-9
6. Weizer AZ, Joshi D, Daignault S, et al. Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer. J Urol 2007; 177: 1287-93
7. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou J,. Guidelines on TaT 1 (Non-muscle invasive) Bladder Cancer, 2009. Available at:. Accessed April 2010
8. Stenzl A, Cowan NC, De Santis M, et al. Guidelines on Bladder Cancer: Muscle-Invasive and Metastatic, 2009. Available at:. Accessed April 2010
9. Chang SS, Alberts G, Cookson MS, Smith JA Jr,. Radical cystectomy is safe in elderly patients at high risk. J Urol 2001; 166: 938-41
10. Clark PE, Stein JP, Groshen SG, et al. Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer 2005; 104: 36-43
11. Prout GR Jr, Wesley MN, Yancik R, Ries LA, Havlik RJ, Edwards BK,. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 2005; 104: 1638-47
12. Chamie K, Hu B, Devere White RW, Ellison LM., Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int 2008; 102: 284-90
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83
14. Epstein JI, Amin MB, Reuter VR, Mostofi FK,. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435-48
15. Hall MC, Chang SS,. Chapter 1. The Management of Bladder Cancer: Diagnosis and Treatment Recommendations. The American Urological Association clinical guidelines: Bladder Cancer Clinical Guideline Update Panel, 2007. Available at:. Accessed April 2010: 1-51
16. Bajorin DF, Dodd PM, Mazumdar M, et al. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol 1999; 17: 3173-81
17. Maione P, Perrone F, Gallo C, et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005; 23: 6865-72
18. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J,. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 1999; 17: 2530-40